Australia markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
33.88+0.59 (+1.77%)
At close: 04:00PM EDT
34.17 +0.29 (+0.86%)
After hours: 07:27PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
523,529
482,375
401,858
365,978
353,874
Cost of revenue
7,630
6,481
5,385
5,281
5,582
Gross profit
515,899
475,894
396,473
360,697
348,292
Operating expenses
Research development
202,007
184,353
130,991
113,864
114,764
Selling general and administrative
191,963
184,259
152,848
122,356
105,326
Total operating expenses
393,970
368,612
283,839
236,220
220,090
Operating income or loss
121,929
107,282
112,634
124,477
128,202
Income before tax
141,116
124,557
116,191
125,006
131,602
Income tax expense
23,093
18,417
14,773
12,494
25,591
Income from continuing operations
118,023
106,140
101,418
112,512
106,011
Net income
118,023
106,140
101,418
112,512
106,011
Net income available to common shareholders
117,203
105,496
101,288
112,512
106,011
Basic EPS
0.97
1.02
0.95
0.97
0.92
Diluted EPS
0.89
0.94
0.87
0.89
0.85
Basic average shares
115,653
103,560
106,787
115,653
115,412
Diluted average shares
125,963
111,742
115,966
125,963
124,194